Virica Biotech Selected as a Lead Project as Part of NIIMBL's $10M Biomanufacturing Projects

Portfolio company, Virica Biotech has been included in a NIIMBL (The National Institute for Innovation in Manufacturing Biopharmaceuticals) $10M program as a lead project in a total of 8 biomanufacturing Projects.  Virica's VSE platform helps to increase viral vector yield by reducing innate cellular antiviral defenses.

For more information on the project and all the participating companies, read the full announcement.